Definium Therapeutics Inc
Definium Therapeutics Inc (DFTX) Covered Calls
Read more
Running DFTX covered calls helps you generate income from Definium Therapeutics Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best DFTX covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If DFTX stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling DFTX covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given DFTX covered call is worth writing.
Definium Therapeutics, Inc. is a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company’s lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
| 2026-11-20 | 7 | 40.00 | 24.69 | 0.05 | 0.25 | 797.00 | 24.84 | 1295.44 | -0.16 | +0.08 | 421 | 0.20 |
| 2026-11-20 | 7 | 37.00 | 15.34 | 0.20 | 0.65 | 512.00 | 15.96 | 832.21 | -0.62 | +0.18 | 1,685 | 0.45 |
| 2026-11-20 | 7 | 36.00 | 12.22 | 0.15 | 1.10 | 407.00 | 12.69 | 661.54 | -0.47 | +0.24 | 312 | 0.95 |
| 2026-11-20 | 7 | 35.00 | 9.10 | 0.40 | 1.00 | 332.00 | 10.35 | 539.63 | -1.25 | +0.28 | 2,871 | 0.60 |
| 2026-11-20 | 7 | 34.00 | 5.99 | 0.45 | 1.85 | 237.00 | 7.39 | 385.22 | -1.40 | +0.38 | 127 | 1.40 |
| 2026-12-18 | 35 | 43.00 | 34.04 | 0.25 | 0.80 | 1117.00 | 34.82 | 363.11 | -0.78 | +0.14 | 110 | 0.55 |
| 2026-12-18 | 35 | 41.00 | 27.81 | 0.20 | 5.00 | 912.00 | 28.43 | 296.47 | -0.62 | +0.36 | 20 | 4.80 |
| 2026-11-20 | 7 | 33.00 | 2.87 | 0.85 | 1.40 | 177.00 | 5.52 | 287.70 | -2.65 | +0.43 | 311 | 0.55 |
| 2026-12-18 | 35 | 40.00 | 24.69 | 0.70 | 0.75 | 862.00 | 26.87 | 280.22 | -2.18 | +0.20 | 329 | 0.05 |
| 2027-01-15 | 63 | 46.00 | 43.39 | 0.30 | 1.35 | 1422.00 | 44.33 | 256.81 | -0.94 | +0.17 | 29 | 1.05 |
As of Nov 13, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank—
- Market cap (M$)4,392
- 52 weeks high-35.45%
- 52 weeks low206.69%
- Analyst recommendationStrong Buy
1.05 - Target price$72.78
126.87% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-09
- P/E—
- Future P/E—
- EPS (ttm)-3.03
- EPS growth next 5 years25.70%
As of Nov 13, 2026